Endolymphatic exclusion for the treatment of pediatric chylous ascites secondary to neuroblastoma resection: report of two cases

Chylous ascites is a rare, but highly morbid complication of oncologic resection, often associated with retroperitoneal lymphadenectomy. Conservative measures with total parenteral nutrition or lipid-reduced formulas constitute the initial mainstay therapy, but not without risks and failures. This r...

Full description

Bibliographic Details
Main Authors: Andrew Woerner, MD, MS, David S. Shin, MD, Jeffrey Forris Beecham Chick, MD, MPH, FSVM, Caitlin A. Smith, MD, Jay F. Sarthy, MD, PhD, Eric J. Monroe, MD
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:Radiology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043320301667
_version_ 1828410868591755264
author Andrew Woerner, MD, MS
David S. Shin, MD
Jeffrey Forris Beecham Chick, MD, MPH, FSVM
Caitlin A. Smith, MD
Jay F. Sarthy, MD, PhD
Eric J. Monroe, MD
author_facet Andrew Woerner, MD, MS
David S. Shin, MD
Jeffrey Forris Beecham Chick, MD, MPH, FSVM
Caitlin A. Smith, MD
Jay F. Sarthy, MD, PhD
Eric J. Monroe, MD
author_sort Andrew Woerner, MD, MS
collection DOAJ
description Chylous ascites is a rare, but highly morbid complication of oncologic resection, often associated with retroperitoneal lymphadenectomy. Conservative measures with total parenteral nutrition or lipid-reduced formulas constitute the initial mainstay therapy, but not without risks and failures. This report describes 2 endolymphatic treatment strategies for iatrogenic chylous ascites following neuroblastoma resection. Lymphatic leaks were identified using intranodal lymphangiography, targeted with cone-beam computed tomographic guidance, and embolized with n-butyl cyanoacrylate. There were no adverse outcomes, with complete resolution of chylous ascites and a mean follow-up of 26 months.
first_indexed 2024-12-10T12:18:45Z
format Article
id doaj.art-8ca2f64aefcb416d83260e2699926e81
institution Directory Open Access Journal
issn 1930-0433
language English
last_indexed 2024-12-10T12:18:45Z
publishDate 2020-07-01
publisher Elsevier
record_format Article
series Radiology Case Reports
spelling doaj.art-8ca2f64aefcb416d83260e2699926e812022-12-22T01:49:09ZengElsevierRadiology Case Reports1930-04332020-07-0115710441049Endolymphatic exclusion for the treatment of pediatric chylous ascites secondary to neuroblastoma resection: report of two casesAndrew Woerner, MD, MS0David S. Shin, MD1Jeffrey Forris Beecham Chick, MD, MPH, FSVM2Caitlin A. Smith, MD3Jay F. Sarthy, MD, PhD4Eric J. Monroe, MD5Interventional Radiology Section, Department of Radiology, University of Washington, 1959 Northeast Pacific Street, Seattle, WA 98195, USAInterventional Radiology Section, Department of Radiology, University of Washington, 1959 Northeast Pacific Street, Seattle, WA 98195, USAInterventional Radiology Section, Department of Radiology, University of Washington, 1959 Northeast Pacific Street, Seattle, WA 98195, USA; Division of Vascular and Interventional Radiology, Department of Radiology, Seattle Children's Hospital, 4800 Sand Point Way Northeast, Seattle, WA 98105, USADepartment of General Surgery, University of Washington and Seattle Children's Hospital, Seattle, WA, USAClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, WA, USAInterventional Radiology Section, Department of Radiology, University of Washington, 1959 Northeast Pacific Street, Seattle, WA 98195, USA; Division of Vascular and Interventional Radiology, Department of Radiology, Seattle Children's Hospital, 4800 Sand Point Way Northeast, Seattle, WA 98105, USA; Corresponding author.Chylous ascites is a rare, but highly morbid complication of oncologic resection, often associated with retroperitoneal lymphadenectomy. Conservative measures with total parenteral nutrition or lipid-reduced formulas constitute the initial mainstay therapy, but not without risks and failures. This report describes 2 endolymphatic treatment strategies for iatrogenic chylous ascites following neuroblastoma resection. Lymphatic leaks were identified using intranodal lymphangiography, targeted with cone-beam computed tomographic guidance, and embolized with n-butyl cyanoacrylate. There were no adverse outcomes, with complete resolution of chylous ascites and a mean follow-up of 26 months.http://www.sciencedirect.com/science/article/pii/S1930043320301667PediatricsOncologyChylous ascitesLymphaticInterventional radiologyCone beam computed tomography
spellingShingle Andrew Woerner, MD, MS
David S. Shin, MD
Jeffrey Forris Beecham Chick, MD, MPH, FSVM
Caitlin A. Smith, MD
Jay F. Sarthy, MD, PhD
Eric J. Monroe, MD
Endolymphatic exclusion for the treatment of pediatric chylous ascites secondary to neuroblastoma resection: report of two cases
Radiology Case Reports
Pediatrics
Oncology
Chylous ascites
Lymphatic
Interventional radiology
Cone beam computed tomography
title Endolymphatic exclusion for the treatment of pediatric chylous ascites secondary to neuroblastoma resection: report of two cases
title_full Endolymphatic exclusion for the treatment of pediatric chylous ascites secondary to neuroblastoma resection: report of two cases
title_fullStr Endolymphatic exclusion for the treatment of pediatric chylous ascites secondary to neuroblastoma resection: report of two cases
title_full_unstemmed Endolymphatic exclusion for the treatment of pediatric chylous ascites secondary to neuroblastoma resection: report of two cases
title_short Endolymphatic exclusion for the treatment of pediatric chylous ascites secondary to neuroblastoma resection: report of two cases
title_sort endolymphatic exclusion for the treatment of pediatric chylous ascites secondary to neuroblastoma resection report of two cases
topic Pediatrics
Oncology
Chylous ascites
Lymphatic
Interventional radiology
Cone beam computed tomography
url http://www.sciencedirect.com/science/article/pii/S1930043320301667
work_keys_str_mv AT andrewwoernermdms endolymphaticexclusionforthetreatmentofpediatricchylousascitessecondarytoneuroblastomaresectionreportoftwocases
AT davidsshinmd endolymphaticexclusionforthetreatmentofpediatricchylousascitessecondarytoneuroblastomaresectionreportoftwocases
AT jeffreyforrisbeechamchickmdmphfsvm endolymphaticexclusionforthetreatmentofpediatricchylousascitessecondarytoneuroblastomaresectionreportoftwocases
AT caitlinasmithmd endolymphaticexclusionforthetreatmentofpediatricchylousascitessecondarytoneuroblastomaresectionreportoftwocases
AT jayfsarthymdphd endolymphaticexclusionforthetreatmentofpediatricchylousascitessecondarytoneuroblastomaresectionreportoftwocases
AT ericjmonroemd endolymphaticexclusionforthetreatmentofpediatricchylousascitessecondarytoneuroblastomaresectionreportoftwocases